Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ANTI-THYMOCYTE GLOBULIN: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

Gender data not available for ANTI-THYMOCYTE GLOBULIN.

Age Information

The average age of patients reporting adverse events with ANTI-THYMOCYTE GLOBULIN is 49.3 years.

Geographic Distribution

The majority of adverse event reports for ANTI-THYMOCYTE GLOBULIN originate from US.

Report Summary & Outcomes

54
Total Reports
54
As Primary/Secondary Suspect
15
Deaths Reported
10
Hospitalizations
2
Life-Threatening

Reporting Timeline

First adverse event report: 20081125. Most recent report: 20140306. View full timeline →

More About ANTI-THYMOCYTE GLOBULIN

ANTI-THYMOCYTE GLOBULIN Full Profile Reports by Year Drug Interactions